Abortion, Spontaneous Clinical Trial
Official title:
Efficacy of the Association of Hyaluronic Acid With High Molecular Weight, α-lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion in Patients at Risk
Verified date | February 2024 |
Source | Lo.Li.Pharma s.r.l |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study aims to verify if the association of high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D, reduces the risk of miscarriage in patients at risk.
Status | Completed |
Enrollment | 100 |
Est. completion date | January 31, 2024 |
Est. primary completion date | September 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - two or more previous spontaneous first trimester abortions without apparent risk factors (idiopathic polyabortion) - Endocrinopathies - Autoimmune diseases - Thrombophililic or coagulation diseases Exclusion Criteria: - Multiple pregnancies - Presence of genetic abnormalities of one or both partners leading to increased risk of fetal aneuploidies - Presence of Mullerian abnormalities in the uterus - Symptoms present at recruitment such as pelvic pain or metrorrhagia |
Country | Name | City | State |
---|---|---|---|
Italy | Dipartimento di Neuroscienze e Scienze riproduttive ed odontostomatologiche | Napoli |
Lead Sponsor | Collaborator |
---|---|
Lo.Li.Pharma s.r.l |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of metrorrhagia and/or pelvic pain in the first trimester of gestation. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05896657 -
Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713
|
N/A | |
Active, not recruiting |
NCT03736681 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage
|
Phase 1 | |
Completed |
NCT03636451 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
|
Phase 3 | |
Completed |
NCT01335802 -
Relation Between Subclinical Hypothyroidism and Outcome of Pregnancy
|
||
Active, not recruiting |
NCT05516810 -
The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles
|
||
Completed |
NCT04446572 -
Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin
|
Phase 2 | |
Completed |
NCT01033903 -
Optimal Treatment of Miscarriage
|
N/A | |
Withdrawn |
NCT02328742 -
Development of a Bioabsorbable Medical Device for the Prevention of Postoperative Intra-uterine Adhesions.
|
N/A | |
Completed |
NCT01762098 -
Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization
|
N/A | |
Active, not recruiting |
NCT04360564 -
RPL: Interval to Live Birth and Adverse Perinatal Outcomes
|
||
Completed |
NCT04791020 -
Topic Cervical Anesthesia Plus Paracervical Blockade for Pain Control During Endouterine Manual Aspiration
|
N/A | |
Recruiting |
NCT03220750 -
University Hospital Advanced Age Pregnant Cohort
|
N/A | |
Completed |
NCT01904669 -
Internet-based Study of Fertility and Early Pregnancy (PEEPS)
|
N/A | |
Not yet recruiting |
NCT00491270 -
Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
|
Phase 3 | |
Active, not recruiting |
NCT02434900 -
Vitamin D and Angiogenic Markers in Odense Child Cohort 1
|
N/A | |
Completed |
NCT03703401 -
The Role of Hydrosalpinx in Recurrent Miscarriage
|
||
Completed |
NCT01788540 -
Intralipid for Recurrent Miscarriage
|
Phase 4 | |
Recruiting |
NCT02633475 -
Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk
|
N/A | |
Completed |
NCT02761772 -
Early Pregnancy Cohort and Preimplantation Factor
|
||
Not yet recruiting |
NCT00256009 -
Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment
|
Phase 4 |